FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 335:1058-1059 October 3, 1996 Number 14 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Esophageal mucosal injury from the noxious effect of gastric contents refluxing up the esophagus is a common condition. Much less common is esophagitis from injurious agents passing down the esophagus, seen in its most dramatic form after the ingestion (usually accidental) of caustic alkali.¹ The potential for medications, such as quinidine, potassium, and tetracycline derivatives, to cause esophagitis or discrete ulcers has recently been recognized.² This effect usually results from prolonged contact of the medication with the esophageal mucosa and the ability of the drug to alter the local conditions, such as tetracycline's production of an acidic pH. It is . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Graham, D. Y., Malaty, H. M. (2001). Alendronate and Naproxen Are Synergistic for Development of Gastric Ulcers. Arch Intern Med 161: 107-110 [Abstract] [Full Text]  
• O'Donnell, J. (2000). Drug-Induced Esophagitis. Journal of Pharmacy Practice 13: 290-296 [Abstract]  
• Singer, F. R., Clemens, T. L., Eusebio, R. A., Bekker, P. J. (1998). Risedronate, a Highly Effective Oral Agent in the Treatment of Patients with Severe Paget's Disease. J. Clin. Endocrinol. Metab. 83: 1906-1910 [Abstract] [Full Text]